Event/Approval
Completed
SIM0725 receives NMPA approval to begin clinical trials in China
Actors and targets
Source
No source quote is linked to this record.
Related events
Same kind only, ranked by embedding similarity to this record.
No source quote is linked to this record.
Same kind only, ranked by embedding similarity to this record.